Emma Linderoth

515 total citations
10 papers, 172 citations indexed

About

Emma Linderoth is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Emma Linderoth has authored 10 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 1 paper in Oncology. Recurrent topics in Emma Linderoth's work include Phagocytosis and Immune Regulation (7 papers), Immune cells in cancer (5 papers) and Cell death mechanisms and regulation (2 papers). Emma Linderoth is often cited by papers focused on Phagocytosis and Immune Regulation (7 papers), Immune cells in cancer (5 papers) and Cell death mechanisms and regulation (2 papers). Emma Linderoth collaborates with scholars based in United Kingdom, Sweden and United States. Emma Linderoth's co-authors include Ingvar Ferby, Bruno Antonsson, Robert Steinfeld, Hanna Appelqvist, Ann‐Charlotte Johansson, Uno Johansson, Karin Öllinger, Katarina Kågedal, Giulio Superti‐Furga and Mark Wong and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Emma Linderoth

9 papers receiving 169 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Linderoth United Kingdom 6 81 69 45 27 22 10 172
Maksim Klimiankou Germany 9 81 1.0× 89 1.3× 82 1.8× 53 2.0× 51 2.3× 32 276
Sara Rhost Sweden 10 83 1.0× 237 3.4× 63 1.4× 22 0.8× 23 1.0× 14 363
Tamara C. Pereboom Netherlands 10 202 2.5× 94 1.4× 61 1.4× 24 0.9× 24 1.1× 10 333
Srikanth Kodali United States 6 148 1.8× 127 1.8× 83 1.8× 69 2.6× 13 0.6× 10 314
Chad Whilding United Kingdom 9 222 2.7× 68 1.0× 19 0.4× 26 1.0× 16 0.7× 13 294
Alexander S. Roesler United States 5 76 0.9× 199 2.9× 42 0.9× 30 1.1× 22 1.0× 7 283
Ronald Rudolf Germany 6 87 1.1× 128 1.9× 29 0.6× 13 0.5× 17 0.8× 8 197
Sebastian Bittner Germany 10 110 1.4× 130 1.9× 66 1.5× 31 1.1× 19 0.9× 11 250
Yingchi Zhang China 6 112 1.4× 27 0.4× 47 1.0× 16 0.6× 8 0.4× 13 206
Rémy Char France 3 126 1.6× 165 2.4× 38 0.8× 33 1.2× 26 1.2× 3 304

Countries citing papers authored by Emma Linderoth

Since Specialization
Citations

This map shows the geographic impact of Emma Linderoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Linderoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Linderoth more than expected).

Fields of papers citing papers by Emma Linderoth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Linderoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Linderoth. The network helps show where Emma Linderoth may publish in the future.

Co-authorship network of co-authors of Emma Linderoth

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Linderoth. A scholar is included among the top collaborators of Emma Linderoth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Linderoth. Emma Linderoth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Krishnamoorthy, Mithunah, Ruth Seelige, Christopher R. Brown, et al.. (2025). Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy. Frontiers in Immunology. 16. 1518787–1518787.
2.
Varga, Balázs, Maryam Faiz, Helena Pivoňková, et al.. (2022). Signal requirement for cortical potential of transplantable human neuroepithelial stem cells. Nature Communications. 13(1). 2844–2844. 5 indexed citations
3.
Viller, Natasja Nielsen, et al.. (2018). Abstract 2720: The CD47-blocking innate immune checkpoint inhibitor, TTI-621, triggers CD47-mediated tumor cell apoptosis. Cancer Research. 78(13_Supplement). 2720–2720. 1 indexed citations
4.
Lin, Gloria H. Y., Vivian Lee, Karen Dodge, et al.. (2017). TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets. PLoS ONE. 12(10). e0187262–e0187262. 51 indexed citations
5.
Lin, Gloria H. Y., Hui Chen, Mark Wong, et al.. (2017). Abstract 2646: Intratumoral delivery of TTI-621 (SIRPαFc), a CD47-blocking immunotherapeutic, inhibits tumor growth and prolongs animal survival in a subcutaneous B cell lymphoma model. Cancer Research. 77(13_Supplement). 2646–2646. 1 indexed citations
6.
Linderoth, Emma, Vivian Lee, Mark Wong, et al.. (2017). Abstract 2653: The anti-myeloma activity of TTI-621 (SIRPαFc), a CD47-blocking immunotherapeutic, is enhanced when combined with a proteasome inhibitor. Cancer Research. 77(13_Supplement). 2653–2653. 5 indexed citations
7.
Viller, Natasja Nielsen, Emma Linderoth, Lisa D. Johnson, et al.. (2016). Abstract B028: Blockade of the CD47 “Do not eat” signal by TTI-621 (SIRPαFc) leads to enhanced antitumor CD8+ T cell responses in vitro. Cancer Immunology Research. 4(11_Supplement). B028–B028. 1 indexed citations
8.
9.
Linderoth, Emma, Oliver Hantschel, Howard Kendrick, et al.. (2012). Mig6 Is a Sensor of EGF Receptor Inactivation that Directly Activates c-Abl to Induce Apoptosis during Epithelial Homeostasis. Developmental Cell. 23(3). 547–559. 42 indexed citations
10.
Appelqvist, Hanna, Ann‐Charlotte Johansson, Emma Linderoth, et al.. (2012). Lysosome-mediated apoptosis is associated with cathepsin D-specific processing of bid at Phe24, Trp48, and Phe183.. PubMed. 42(3). 231–42. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maksim Klimiankou Breakdown of academic impact, for papers by Sara Rhost Breakdown of academic impact, for papers by Tamara C. Pereboom Breakdown of academic impact, for papers by Srikanth Kodali Breakdown of academic impact, for papers by Chad Whilding Breakdown of academic impact, for papers by Alexander S. Roesler Breakdown of academic impact, for papers by Ronald Rudolf Breakdown of academic impact, for papers by Sebastian Bittner Breakdown of academic impact, for papers by Yingchi Zhang Breakdown of academic impact, for papers by Rémy Char
Rankless by CCL
2026